首页 | 本学科首页   官方微博 | 高级检索  
     


Structural biology of presenilin 1 complexes
Authors:Yi?Li,Christopher?Bohm,Roger?Dodd,Fusheng?Chen,Seema?Qamar,Gerold?Schmitt-Ulms,Paul?E?Fraser,Peter?H?St George-Hyslop  author-information"  >  author-information__contact u-icon-before"  >  mailto:p.hyslop@utoronto.ca"   title="  p.hyslop@utoronto.ca"   itemprop="  email"   data-track="  click"   data-track-action="  Email author"   data-track-label="  "  >Email author
Affiliation:1.Cambridge Institute for Medical Research, Wellcome Trust MRC Building,Addenbrookes Hospital,Cambridge,UK;2.Tanz Centre for Research in Neurodegenerative Diseases and Depts of Medicine, Laboratory Medicine and Pathobiology and Medical Biophysics,University of Toronto,Toronto,Canada
Abstract:The presenilin genes were first identified as the site of missense mutations causing early onset autosomal dominant familial Alzheimer's disease. Subsequent work has shown that the presenilin proteins are the catalytic subunits of a hetero-tetrameric complex containing APH1, nicastrin and PEN-2. This complex (variously termed presenilin complex or gamma-secretase complex) performs an unusual type of proteolysis in which the transmembrane domains of Type I proteins are cleaved within the hydrophobic compartment of the membrane. This review describes some of the molecular and structural biology of this unusual enzyme complex. The presenilin complex is a bilobed structure. The head domain contains the ectodomain of nicastrin. The base domain contains a central cavity with a lateral cleft that likely provides the route for access of the substrate to the catalytic cavity within the centre of the base domain. There are reciprocal allosteric interactions between various sites in the complex that affect its function. For instance, binding of Compound E, a peptidomimetic inhibitor to the PS1 N-terminus, induces significant conformational changes that reduces substrate binding at the initial substrate docking site, and thus inhibits substrate cleavage. However, there is a reciprocal allosteric interaction between these sites such that prior binding of the substrate to the initial docking site paradoxically increases the binding of the Compound E peptidomimetic inhibitor. Such reciprocal interactions are likely to form the basis of a gating mechanism that underlies access of substrate to the catalytic site. An increasingly detailed understanding of the structural biology of the presenilin complex is an essential step towards rational design of substrate- and/or cleavage site-specific modulators of presenilin complex function.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号